FDAnews
www.fdanews.com/articles/115165-genzyme-sees-no-supply-disruption-after-fda-letter

Genzyme Sees No Supply Disruption After FDA Letter

March 6, 2009
Genzyme Corp said it does not expect production of its biggest-selling drugs to be disrupted by its receipt of a warning letter from U.S. regulators over flaws at one of its manufacturing facilities.
CNN Money